Recent developments on treatment strategies and the prognosis of dermatomyositis: a review
Dermatomyositis is an autoimmune disease affecting both skin and muscle. Steroids are the first line treatment. However, no consensus regarding dosing, length of treatment, tapering speed, or when to add which immunosuppressant in case of steroid resistance, has been reached, as randomized-controlle...
Main Authors: | Verena Isak, Joseph L. Jorizzo |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2018-07-01
|
Series: | Journal of Dermatological Treatment |
Subjects: | |
Online Access: | http://dx.doi.org/10.1080/09546634.2017.1403549 |
Similar Items
-
PANNICULITIS IN DERMATOMYOSITIS
by: O. A. Antelava, et al.
Published: (2016-07-01) -
Special papers Diagnostic and therapeutic advances in dermatomyositis
by: Dominik Samotij, et al.
Published: (2015-06-01) -
The relevance of anti-Jo-1 autoantibodies in patients with definite dermatomyositis
by: Vanessa Posener de Andrade, et al.
Published: (2021-02-01) -
Dermatomyositis and HIV
by: Mamata Chand, et al.
Published: (2016-12-01) -
Assessment and management of a patient with paraneoplastic dermatomyositis
by: Ioan-Cristian Lupescu, et al.
Published: (2017-12-01)